The Fundació Rossend Carrasco Formiguera attends some 800 patients (both in outpatient clinics and in hospitalization situations) and carries out continuous follow-ups that contribute to the Quality Control of the service we provide.
In therapeutic terms, we are committed to “evidence-based medicine”, that is the use of pharmacological and nonpharmacological resources that have been proven by rigorous research. We are also committed to the philosophy of empowerment, that is the patient, after having received all the necessary information, takes the therapeutic decisions.
In terms of diagnosis, we have a laboratory for analyses, which makes it possible to determine basic biochemistry, glycosylated hemoglobin and albumin. We also have a non-mydriatic retinal camera that allows us to perform retinal photography without dilating the pupil.
Our experience with insulin pumps began in 1996, coinciding with the improvement in performance of these instruments. To date, we have placed 90 pumps, 46 of which we continue to monitor today.
Since October 2000, the FRCF has been working with continuous glucose sensors that permit a continuous measurement of glucose over a period of 6 to 14 days, thus allowing the adjustment of therapeutic These real-time sensors have been in use since 2008 and are the first step toward an artificial pancreas scheduled for 2019.
Other examinations have been incorporated as ambulatory continuous recording of blood pressure (MAP) and ambulatory study of sleep quality (ApneaLink).
At the FRCF, we have created the new digital info-card that contains the complete medical history of the patient, including treatment, blood glucose levels and other relevant information